GU Ventures AB

Carl-Peter Mattsson is a Strategic Coordinator at New Modality Support with over 25 years of experience in international venture capital across multiple industries. His background includes supporting entrepreneurs from early-stage development through scaling to global companies and mentoring during business growth phases.

Andreas Pfister is a business developer at GU Ventures with a background from Chalmers School of Entrepreneurship, having run his own company since around 2010. His work has focused on company building, business development, technical sales, and commercialization, initially in building physics and moisture technology (where the company developed a patented solution) and later in energy and solar energy. He also works as a ski instructor, avalanche technician, and training leader.

Daniel Poté is Chairperson of the Board at Oscillution and Business Developer at GU Ventures. He brings over 20 years of experience in product management, market development, and strategic leadership across medical technology, biotechnology, and digitalization. His background encompasses life sciences, medical devices, diagnostics, e-health, business development, and strategy across healthcare and technology sectors.

Eduarde Rohner holds a PhD in Biomedical Sciences and currently serves as Project Lead at New Modality Support. His research background includes work under Kenneth Chien at the Karolinska Institutet, where he studied mRNA applications with stem cell-derived cardiomyocytes and mesenchymal stem cells, followed by a role as project lead at SmartCella Solutions managing pre-clinical development programs. He has also worked as a business developer at GU Ventures leading the NMS initiative and serves as a board member of the Swiss Chamber of Commerce.

Fredrik Wångsell is a Business Development Manager at GU Ventures and OlinoNova Hub with over 15 years of experience in medicinal chemistry, drug discovery, and translational research. He specializes in advancing scientific innovations from academic discovery through preclinical development and venture creation, with expertise in therapeutic oligonucleotides, intellectual property strategy, regulatory planning, and fundraising. His work bridges academia, industry, and investment ecosystems to facilitate technology transfer and commercialization of scientific discoveries.

Melisha Linnell is a kommunikatör at FUHS - Föreningen Universitetsholdingbolag i Sverige based in Gothenburg, Sweden. With 23 years of experience in sound and media, she holds a bachelor's degree in music production from Dalarna University and has studied in an Audiovisual Studies Master's program, complemented by web development training from KY-Academy Lindholmen. Her professional background includes 11 years operating a recording studio, lecturing at the University of Theater and Music in Gothenburg from 2017 to 2022, work with venture organizations including GU Ventures and West Swedish Incubators, and production of music for artists, bands, podcasts, and advertising, alongside founding the non-profit association Eqlovesmusic.

Mikael Funa is a Business Developer and Investment Manager at GU Ventures with experience across IT and technology sectors. His background includes business development, funding acquisition, and sales and marketing strategy, with particular focus on supporting startup scaling and team building. Funa has worked across multiple industries and maintains expertise in growth strategy and investment navigation.

Per Hulthén is a founder and advisor specializing in venture strategy, financing, and governance for early-stage companies. He has built and led venture-backed technology companies including Illuminate Labs, which was acquired by Autodesk, and LumenRadio, which listed on Nasdaq First North, and has invested as a business angel and seed-stage investor. Through Autlook AB and his Financial Design for Startups training program, he advises founders, investors, and ecosystem participants on financing strategy and ownership structures, drawing on over a decade of entrepreneurship research and teaching conducted with universities and public institutions.

Sara Malcus holds a PhD in Medicine and serves as Chair of the Board of Directors at Inicure AB. Over the past 15 years, she has held executive leadership and board positions focused on business creation, organizational transformation, and strategy execution across life science and innovation sectors. Her background combines scientific training with experience in scaling businesses and developing leadership teams.

Sofia Hjelmberg is Events Director at EUVC, where she works on investor relations and venture management initiatives. She has experience managing strategic and operational projects within startup environments, with a focus on relationship building and network development to support organizational objectives.

Stefan Thundal joined GU Ventures as a business developer. His background is in advanced industrial technology, international business development, and the commercialization of deeptech companies, with experience bringing technology-driven innovations from concept and development through to market.

Elisabeth Gustafsson serves as Chairman of the Board at AquaFood AB and has held positions including Project Manager, CTO, and CEO across industrial and technology-oriented companies with global operations. Her background encompasses sales, business development, and board-level experience, with particular focus on medtech and deeptech sectors.

Helena Lundquist holds an economics degree from Handelshögskolan in Göteborg with a focus on marketing (1997) and has worked in the pharmaceutical industry since 1998 across multiple therapeutic areas in public affairs, market access, and marketing roles. She currently serves as business developer at GU Ventures, supporting research-based life science startups from Gothenburg University, and holds board positions at several life science companies including Videm, CerInvent, Exocure, Implexion, Simplexia, Navari Surgical, and AMiLion.

Richard Raimer is Finansdirektör at GU Ventures. With over 15 years of experience, he has held positions as vice president, chief financial officer, and finance director at companies operating in international trade, transport, oil storage, and asset management. His background spans business development and finance across markets in Japan, Europe, and North and South America.

Sara Lorentzon serves as chair at RunaBio. She has experience as an investment analyst focusing on startups across sectors and has worked in business development within early-stage pharmaceutical companies.